Health
With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine – FiercePharma
AstraZeneca’s target window to apply for emergency use authorization of its troubled COVID-19 vaccine in the U.S. has passed. But the company still plans to seek…
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed.
A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency nod in America in the first half of April.
Assuming that the approval will take place in a fast way, we hope to deliver 30 million doses instantly,…
-
General12 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News23 hours agoDeaths of Karen Edwards, Tim Thomson, and Gordon Twaddle re-examined in inquest
-
Noosa News16 hours agoNew One Nation branch | Noosa Today
-
Business13 hours agoWhere are the buying opportunities in today’s stock market?